SCHEMBL28708396

SCHEMBL28708396

C=Cc1cnn(CC#N)c1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12890288 0.81 KDM4E (0.35) FEN1KDM4EALDH1A1HPGD
SCHEMBL23759570 0.75
SCHEMBL18010537 0.75
SCHEMBL1854337 0.75
SCHEMBL612055 0.71
SCHEMBL15322352 0.71
SCHEMBL15322243 0.71
SCHEMBL15885884 0.71
SCHEMBL15033960 0.71
SCHEMBL24883419 0.68 JAK2 (0.35) FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114072387-B Indazole compound, pharmaceutical composition and application thereof 暨南大学 2024-03-08 CN disclosed
EP-4056558-A1 INDAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION OF SAME, AND APPLICATIONS THEREOF Jinan University (CN) 2022-09-14 EP disclosed
US-20220281821-A1 INDAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS JINAN UNIVERSITY (CN) 2022-09-08 US disclosed
CN-114072387-A Indazole compound and medicinal composition and application thereof 暨南大学 2022-02-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220281821-A1 INDAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS TNK2, TNNI3K, CSNK1G3 FEN1 3979/4885KDM4E 3236/4885ALDH1A1 3015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.